Clinical Trials History Policy Research and Development 
Cannabis Law Report
AUGUST 10, 2021
As psychedelic therapy trials approach FDA approval, researchers express the urgent need to ensure effectiveness and accessibility to communities of color. Madison Natarajan, MS. – August 5, 2021.
MMJ Recs
MAY 9, 2024
These professionals can provide valuable insights into whether medical cannabis is a suitable option based on the veteran’s medical history, current conditions, and treatment goals. Advocates continue to push for policy changes that would ensure veterans have the same access to medical marijuana as other patients.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
SEPTEMBER 22, 2021
Despite this, the Home Office “fails to act, perpetuating what can be considered the worst research blackout in scientific history,” according to the Conservative Drug Policy Reform Group (CDPRG), of which Mr Blunt is chairman. The first part of their review was published in July and the second part of the work is now underway.
Cannabis Law Report
JUNE 19, 2022
The Center for Psychedelic Drug Research and Education (CPDRE) was approved by the Ohio State College of Social Work faculty in January, and its director, Assistant Professor of Social Work Alan Davis , officially took the helm in March. Initial goals of the center are focused on research and educational initiatives.
Cannabis Law Report
FEBRUARY 28, 2022
In the past two decades, pioneering research has rekindled interest in the therapeutic use of psychedelic substances such as psilocybin, ibogaine, and dimethyltryptamine (DMT). Indigenous communities have used them for centuries, and researchers studied them in the 1950s and ‘60s. Glenn Cohen & Mason Marks. 20 February 2022.
Cannabis Law Report
NOVEMBER 15, 2021
a manufacturer of LinearDNA™ via PCR for nucleic acid therapeutics and diagnostics, today announced the receipt of repeat orders from diagnostic customers and a first Contract Research Organization (CRO) order from a new biotherapeutic customer, a federally funded research and development laboratory focused on cancer research.
Cannabis Law Report
NOVEMBER 23, 2021
. “If a small number of companies secure wide swaths of intellectual property early on, then the beneficial impact of that shift may be blunted,” warn researchers. Patents on Psychedelics: The Next Legal Battlefront of Drug Development. Read more at [link]. Harvard Law Review Forum, Vol. 135, 2022 (Forthcoming).
Expert insights. Personalized for you.
105 
Let's personalize your content